## Core Concept
Severe cerebral malaria is a life-threatening condition caused by Plasmodium falciparum infection. Treatment involves antimalarial drugs, and managing complications such as hypoglycemia is crucial. Hypoglycemia in this context can arise from the disease process itself or as an adverse effect of treatment.

## Why the Correct Answer is Right
Quinine is used in the treatment of severe malaria, including cerebral malaria. One of the known side effects of quinine is that it can cause **hypoglycemia**. This occurs because quinine stimulates the release of insulin from the pancreas. In the context of severe malaria, where the body's glucose homeostasis is already compromised, the insulin-releasing effect of quinine can lead to episodes of hypoglycemia.

## Why Each Wrong Option is Incorrect
* **Option A:** While artesunate is a first-line treatment for severe malaria, it is not commonly associated with causing hypoglycemia directly.
* **Option B:** Chloroquine can be used for malaria treatment but is less commonly associated with hypoglycemia compared to quinine.
* **Option C:** Mefloquine is another antimalarial drug but is not typically known for causing hypoglycemia.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is to monitor blood glucose levels in patients treated with quinine for severe malaria, as quinine-induced hypoglycemia can be a complication. This is particularly important because the symptoms of hypoglycemia can be masked by the symptoms of malaria or its treatment.

## Correct Answer Line
**Correct Answer: D. Quinine.**